HIGHLIGHTS
- who: Hedieh Yousefnejad and colleagues from the Shiraz University of Medical Sciences, Shiraz, Iran have published the Article: Medicine and Therapies Nigella sativa powder for helicobacter pylori infected patients: randomized doubleblinded placebo-controlled clinical trial, in the Journal: (JOURNAL)
- what: This study was also registered in the Iranian Registry of Clinical Trials (IRCT20170916036204N7) and was conducted between October 2017 and September 2018. The aim of the study was explained to all the subjects and informed written consent was obtained. It is necessary to mention that in the previous article, the authors demonstrated that supplementation with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.